Potential therapeutic strategy to treat substance abuse related disorders

Sulie L. Chang*

Institute of NeuroImmune Pharmacology and Department of Biological Sciences, Seton Hall University, South Orange,
NJ 07079, USA

The “Potential therapeutic strategy to treat substance-abuse-related disorders” session was chaired by Dr. Sulie L. Chang, director of NeuroImmune Phamacology at Seton Hall University. The four presenters were: Dr Wenzhe Ho (Miniway to stop HIV/HCV), Dr Ru-Band Lu (Low dose of memantine in the treatment of opioid dependence in human), Dr Ping Zhang (Treatment of alcohol-related disorders: Learning from stem/progenitor cells), and Dr Yun-Hsiang Chen (Treatment of methamphetamine abuse: An antibody-based immunotherapy approach).

Keywords:Antibody-based immunotherapy, HIV-1Tg rat, Immunocompromised diseases, Memantine, Neuroimmune axis, TLR3 signaling